Skip to main
HALO
HALO logo

Halozyme Therapeutics (HALO)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Halozyme Therapeutics (HALO) Stock

About Halozyme Therapeutics (HALO)

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gre...read more
Market cap$6.41B
Yesterday's volume102
Revenue (TTM)$1.08B
Avg. daily volume2.62M
EBITDA (TTM)$679.06M
Open$52.66
Price / earnings ratio13.80x
Yesterday's range$51.06 - $53.44
Debt / equity312.57x
52 week range$42.01 - $70.51
5 year debt / equity697.63x
Beta (LTM)0.65x
Interest coverage30.48x
Dividend & yield$0.00 (0.00%)
Current ratio8.39x
Ex-dividend date
Next earningsAug 5, 2025
Dividend payable date

Halozyme Therapeutics Stock Rating

What analysts recommend for HALO stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 30%
Buy 17%
Hold 43%
Sell 9%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for HALO stock is $6.41B

The current P/E ratio for HALO stock is 13.8

The 52-week high for HALO stock is $70.51. The current HALO stock price $undefined is 100.00% below its 52-week high

The 52-week low for HALO stock is $42.01. The current HALO stock price $undefined has increased 100.00% from its 52-week low

No, the HALO stock does not pay dividends to its shareholders

The target price for HALO stock is $40.28 based on the average of what a group of analyst think HALO stock could be worth at a future date. This is not a prediction by Public.com

How to buy HALO stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in HALO stock

    Navigate to the Explore page. Then, type HALO into the search bar. When you see HALO stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased HALO stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Halozyme Therapeutics Stock Earnings

The value each HALO share was expected to gain vs. the value that each HALO share actually gained.

Halozyme Therapeutics (HALO) reported Q1 2025 earnings per share (EPS) of $1.11, beating estimates of $0.94 by 18.09%. In the same quarter last year, Halozyme Therapeutics's earnings per share (EPS) was $0.79. Halozyme Therapeutics is expected to release next earnings on 08/05/2025, with an earnings per share (EPS) estimate of $1.20.

Buy Halozyme Therapeutics (HALO) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.